Cleared Traditional

K182579 - Omron Model BP7900 Blood Pressure Monit...

K182579 is the FDA 510(k) clearance for Omron Model BP7900 Blood Pressure Monit... by Omron Healthcare, Inc.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 176-day FDA review.

K182579 · Omron Healthcare, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2019
Decision
176d
Days
Class 2
Risk

K182579 is an FDA 510(k) clearance for the Omron Model BP7900 Blood Pressure Monitor + EKG. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Omron Healthcare, Inc. (Lake Forest, US). The FDA issued a Cleared decision on March 14, 2019 after a review of 176 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Omron Healthcare, Inc. devices

Submission Details

510(k) Number K182579 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 19, 2018
Decision Date March 14, 2019
Days to Decision 176 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d slower than avg
Panel avg: 125d · This submission: 176d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Experien Group
Ronald S. Warren

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 503
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K182579.
GMC Upper Arm Automatic Blood Pressure Monitor
K181931 · Gmc, Inc. · Apr 2019
Arm Blood Pressure Monitor
K183491 · Xuzhou Yongkang Electronic Science Technology Co., Ltd. · Mar 2019
A&D Medical Blood Pressure Monitors
K173191 · A&D Company, Ltd. · Mar 2019
Microlife Digital Blood Pressure Monitor
K183469 · Microlife Intellectual Property GmbH · Mar 2019
Electronic Blood Pressure Monitor
K182495 · Shenzhen Jumper Medical Equipment Co., Ltd. · Mar 2019
GMC Wrist Automatic Blood Pressure Monitor
K181930 · Gmc, Inc. · Feb 2019